Swedish Orphan Biovitrum Ab (BIOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BIOVF | ROIV | RGEN | ||
| Company | Swedish Orphan Biovitrum Ab | Roivant Sciences Ltd | Repligen Corp | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 28.3000 | 11.65 | 139.61 | ||
| High | 28.3000 | 11.97 | 142.11 | ||
| Low | 28.3000 | 11.62 | 136.54 | ||
| Last | 28.3000 | 11.82 | 141.76 | ||
| Change | -3.0800 | +0.33 | +2.86 | ||
| % Change | -9.82% | +2.87% | +2.06% | ||
| Volume | 200 | 7,197,500 | 660,000 | ||
| 20-Day Average Volume | 1,005 | 4,562,355 | 706,255 | ||
| Previous Close | 31.3800 | 11.49 | 138.90 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 28.0941 | 11.65 | 138.55 | ||
| 20-Day Raw Stochastic | 57.89% | 72.09% | 61.41% | ||
| 20-Day Relative Strength | 52.56% | 52.84% | 51.22% | ||
| Weighted Alpha | N/A | +24.95 | -15.14 | ||
| Today's Opinion | N/A | 72% Buy | 72% Sell | ||
| Previous Opinion | N/A | 40% Buy | 88% Sell | ||
| Last Month's Opinion | N/A | 64% Buy | 64% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -9.60% since 09/20/24 | +1.55% since 11/14/24 | -0.47% since 11/14/24 | ||
| Low | 28.3000 on 11/18/24 | 11.05 on 11/18/24 | 121.52 on 11/15/24 | ||
| High | 32.0100 on 10/25/24 | 11.97 on 11/21/24 | 142.11 on 11/21/24 | ||
| 1-Month | |||||
| %Chg | -4.07% since 10/03/24 | +1.72% since 10/21/24 | -4.99% since 10/21/24 | ||
| Low | 28.3000 on 11/18/24 | 11.05 on 11/18/24 | 121.52 on 11/15/24 | ||
| High | 32.0100 on 10/25/24 | 12.12 on 11/11/24 | 154.48 on 11/12/24 | ||
| 3-Month | |||||
| %Chg | +17.55% since 08/05/24 | +0.25% since 08/21/24 | -7.32% since 08/21/24 | ||
| Low | 28.3000 on 11/18/24 | 11.05 on 11/18/24 | 121.52 on 11/15/24 | ||
| High | 32.2500 on 09/17/24 | 13.06 on 09/09/24 | 154.48 on 11/12/24 | ||
| 6-Month | |||||
| %Chg | +9.88% since 05/03/24 | +5.25% since 05/21/24 | -15.06% since 05/21/24 | ||
| Low | 24.0750 on 08/05/24 | 10.00 on 08/05/24 | 113.50 on 06/20/24 | ||
| High | 32.2500 on 09/17/24 | 13.06 on 09/09/24 | 172.65 on 08/01/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,353,028 | 8,497,108 | 7,782,150 | ||
| Shares Outstanding, K | 295,160 | 739,522 | 56,027 | ||
| Annual Sales | 2,086,200,000 | 124,800,000 | 638,760,000 | ||
| Annual Net Income | 227,170,000 | 4,348,930,000 | 41,580,000 | ||
| Last Quarter Sales | 508,280,000 | 4,480,000 | 154,870,000 | ||
| Last Quarter Net Income | 20,920,000 | -230,180,000 | -650,000 | ||
| 60-Month Beta | 0.56 | 1.24 | 0.96 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.07 on 07/16/24 | -0.29 on 11/12/24 | 0.43 on 11/12/24 | ||
| Latest Earnings Date | 11/25/24 | 11/12/24 | 11/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 46.15 | 0.00 | 93.79 | ||